Establishment Labs Holdings Inc. (ESTA): Price and Financial Metrics


Establishment Labs Holdings Inc. (ESTA): $71.53

-0.10 (-0.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ESTA POWR Grades


  • Sentiment is the dimension where ESTA ranks best; there it ranks ahead of 82.11% of US stocks.
  • The strongest trend for ESTA is in Quality, which has been heading up over the past 48 weeks.
  • ESTA's current lowest rank is in the Value metric (where it is better than 31.08% of US stocks).

ESTA Stock Summary

  • ESTA's went public 3.18 years ago, making it older than merely 9.05% of listed US stocks we're tracking.
  • ESTA's price/sales ratio is 15.18; that's higher than the P/S ratio of 87.87% of US stocks.
  • Revenue growth over the past 12 months for Establishment Labs Holdings Inc comes in at 36.55%, a number that bests 81.36% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Establishment Labs Holdings Inc are PWFL, VAPO, CSII, OSIS, and TELA.
  • Visit ESTA's SEC page to see the company's official filings. To visit the company's web site, go to www.establishmentlabs.com.

ESTA Valuation Summary

  • In comparison to the median Healthcare stock, ESTA's EV/EBIT ratio is 584.64% lower, now standing at -142.
  • ESTA's price/earnings ratio has moved down 65.4 over the prior 38 months.
  • ESTA's price/sales ratio has moved up 6.6 over the prior 38 months.

Below are key valuation metrics over time for ESTA.

Stock Date P/S P/B P/E EV/EBIT
ESTA 2021-08-31 15.9 25.9 -80.3 -142.0
ESTA 2021-08-30 15.2 24.8 -76.9 -135.9
ESTA 2021-08-27 15.4 25.0 -77.6 -137.1
ESTA 2021-08-26 15.2 24.8 -77.0 -136.0
ESTA 2021-08-25 15.5 25.2 -78.2 -138.1
ESTA 2021-08-24 15.5 25.3 -78.6 -138.9

ESTA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ESTA has a Quality Grade of C, ranking ahead of 34.08% of graded US stocks.
  • ESTA's asset turnover comes in at 0.728 -- ranking 46th of 183 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows ESTA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.728 0.637 -0.128
2021-03-31 0.584 0.631 -0.186
2020-12-31 0.532 0.620 -0.299
2020-09-30 0.550 0.661 -0.286
2020-06-30 0.586 0.650 -0.382
2020-03-31 0.734 0.634 -0.387

ESTA Price Target

For more insight on analysts targets of ESTA, see our ESTA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $88.00 Average Broker Recommendation 1.33 (Strong Buy)

ESTA Stock Price Chart Interactive Chart >

Price chart for ESTA

ESTA Price/Volume Stats

Current price $71.53 52-week high $88.66
Prev. close $71.63 52-week low $16.50
Day low $69.75 Volume 106,700
Day high $72.29 Avg. volume 102,090
50-day MA $72.63 Dividend yield N/A
200-day MA $65.73 Market Cap 1.70B

Establishment Labs Holdings Inc. (ESTA) Company Bio


Establishment Labs Holdings Inc., a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue. The company sells its products through exclusive distributors and direct sales force in 60 countries worldwide. The company was founded in 2004 and is based in Alajuela, Costa Rica.


ESTA Latest News Stream


Event/Time News Detail
Loading, please wait...

ESTA Latest Social Stream


Loading social stream, please wait...

View Full ESTA Social Stream

Latest ESTA News From Around the Web

Below are the latest news stories about Establishment Labs Holdings Inc that investors may wish to consider to help them evaluate ESTA as an investment opportunity.

Establishment Labs Launches Motiva Flora Tissue Expander in Europe and Other CE Mark Countries

SANTA BARBARA, Calif., September 02, 2021--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, held a symposium at the London Breast Meeting on Thursday, September 2, 2021, marking the official launch of the company’s Motiva Flora® tissue expander in Europe and other CE Mark countries.

Yahoo | September 2, 2021

Establishment Labs Holdings Inc.: Establishment Labs to Launch Motiva Flora Tissue Expander at London Breast Meeting on September 2, 2021

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women''s health and wellness, principally in breast aesthetics and reconstruction, today

FinanzNachrichten | August 20, 2021

Establishment Labs to Launch Motiva Flora Tissue Expander at London Breast Meeting on September 2, 2021

SANTA BARBARA, Calif., August 20, 2021--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it will host an event on September 2, 2021 marking the official launch of the company’s Motiva Flora® tissue expander in Europe and other CE Mark countries. Motiva Flora offers several notable advances, including Establishment Labs’ patented SmoothSilk®

Yahoo | August 20, 2021

Is Establishment Labs Holdings (NASDAQ:ESTA) Using Debt Sensibly?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Yahoo | August 18, 2021

CORRECTING and REPLACING Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit

SANTA BARBARA, Calif., August 11, 2021--Presentation time in the release dated August 2, 2021, should read 8:00 am PT on Thursday, August 12, 2021 (instead of 8 am ET).

Yahoo | August 11, 2021

Read More 'ESTA' Stories Here

ESTA Price Returns

1-mo -1.99%
3-mo -15.75%
6-mo 23.22%
1-year 314.19%
3-year 193.88%
5-year N/A
YTD 90.04%
2020 36.08%
2019 0.88%
2018 N/A
2017 N/A
2016 N/A

Continue Researching ESTA

Here are a few links from around the web to help you further your research on Establishment Labs Holdings Inc's stock as an investment opportunity:

Establishment Labs Holdings Inc (ESTA) Stock Price | Nasdaq
Establishment Labs Holdings Inc (ESTA) Stock Quote, History and News - Yahoo Finance
Establishment Labs Holdings Inc (ESTA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.977 seconds.